Criteria for evaluating response and outcome in clinical trials for children with juvenile myelomonocytic leukemia
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Haematologica. - 100, 1 (2015) , 17-22, ISSN: 1592-8721
- Ereignis
-
Veröffentlichung
- (wo)
-
Freiburg
- (wer)
-
Universität
- (wann)
-
2020
- Urheber
- DOI
-
10.3324/haematol.2014.109892
- URN
-
urn:nbn:de:bsz:25-freidok-1747349
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:27 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
Entstanden
- 2020
Ähnliche Objekte (12)
Current treatment of juvenile myelomonocytic leukemia
Practical considerations for diagnosis and management of patients and carriers
GFI136N as a therapeutic and prognostic marker for myelodysplastic syndrome
Transient apoptosis inhibition by Bcl-xL overexpression during hematopoietic stem cell transplantation
Comprehensive assessments and related interventions to enhance the long-term outcomes of child, adolescent and young adult cancer survivors - presentation of the CARE for CAYA-Program study protocol and associated literature review
BH3 mimetics and azacitidine show synergistic effects on juvenile myelomonocytic leukemia
BH3 mimetics and azacitidine show synergistic effects on juvenile myelomonocytic leukemia
Pädiatrische Hämatologie und Onkologie
Pearson syndrome: a multisystem mitochondrial disease with bone marrow failure
RAS-pathway mutation patterns define epigenetic subclasses in juvenile myelomonocytic leukemia
CREBBP is a target of epigenetic, but not genetic, modification in juvenile myelomonocytic leukemia
CircRNAs dysregulated in juvenile myelomonocytic leukemia: CircMCTP1 stands out
Current treatment of juvenile myelomonocytic leukemia
Practical considerations for diagnosis and management of patients and carriers
GFI136N as a therapeutic and prognostic marker for myelodysplastic syndrome
Transient apoptosis inhibition by Bcl-xL overexpression during hematopoietic stem cell transplantation
Comprehensive assessments and related interventions to enhance the long-term outcomes of child, adolescent and young adult cancer survivors - presentation of the CARE for CAYA-Program study protocol and associated literature review
BH3 mimetics and azacitidine show synergistic effects on juvenile myelomonocytic leukemia
BH3 mimetics and azacitidine show synergistic effects on juvenile myelomonocytic leukemia
Pädiatrische Hämatologie und Onkologie
Pearson syndrome: a multisystem mitochondrial disease with bone marrow failure
RAS-pathway mutation patterns define epigenetic subclasses in juvenile myelomonocytic leukemia
CREBBP is a target of epigenetic, but not genetic, modification in juvenile myelomonocytic leukemia
CircRNAs dysregulated in juvenile myelomonocytic leukemia: CircMCTP1 stands out
Current treatment of juvenile myelomonocytic leukemia
Practical considerations for diagnosis and management of patients and carriers
GFI136N as a therapeutic and prognostic marker for myelodysplastic syndrome
Transient apoptosis inhibition by Bcl-xL overexpression during hematopoietic stem cell transplantation
Comprehensive assessments and related interventions to enhance the long-term outcomes of child, adolescent and young adult cancer survivors - presentation of the CARE for CAYA-Program study protocol and associated literature review
BH3 mimetics and azacitidine show synergistic effects on juvenile myelomonocytic leukemia
BH3 mimetics and azacitidine show synergistic effects on juvenile myelomonocytic leukemia
Pädiatrische Hämatologie und Onkologie
Pearson syndrome: a multisystem mitochondrial disease with bone marrow failure
RAS-pathway mutation patterns define epigenetic subclasses in juvenile myelomonocytic leukemia
CREBBP is a target of epigenetic, but not genetic, modification in juvenile myelomonocytic leukemia